Price History

Hover for the daily close. The dotted line marks the period open.

Compare MLAB with… →

MLAB Key Statistics

As of Sep 4, 2026

Trading

Open: $126.09
Previous Close: $128.53
Day's Range: 125.35–128.29
52-Week Range: 58.83–132.70
Volume: 100.60K
Beta: 0.96

Valuation

Market Cap: $715.04M
P/E Ratio: 150.33
Forward P/E: 12.44
P/S ratio: 2.86
EPS (ttm): 0.85

Financials (FY)

Revenue (FY): $249.13M+3.38%
Net Income (FY): $6.71M
Profit margin: 1.92%
Shares Outstanding: 5.60M
1-Year Return: +99.67%

Dividend and dates

Dividend: $0.64+0.50%
Ex-Dividend Date: August 31, 2026
Earnings Date: November 5, 2026
Avg Volume: 191.00K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

MLAB Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

+68.27%−49.18%+63.30%

2016*2017201820192020202120222023202420252026*

Year	Return
2026 (partial year)	+63.30%
2025	−40.05%
2024	+26.56%
2023	−36.65%
2022	−49.18%
2021	+14.73%
2020	+15.22%
2019	+20.01%
2018	+68.27%
2017	+1.74%
2016 (partial year)	+18.67%

As of September 4, 2026.

MLAB Revenue and Earnings by Fiscal Year

FY ends March

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$249.13M	$6.71M	2.7%
2024	$240.98M	−$1.97M	−0.8%
2023	$216.19M	−$254.25M	−117.6%
2022	$219.08M	$930.00K	0.4%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$249.13M	$158.27M	$18.51M	$6.71M	2.7%
2024	$240.98M	$150.87M	$16.34M	−$1.97M	−0.8%
2023	$216.19M	$133.25M	$2.46M	−$254.25M	−117.6%
2022	$219.08M	$133.69M	$3.32M	$930.00K	0.4%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

MLAB Dividend History

’16’17’18’19’20’21’22’23’24’25’26*

$0.64+0.0% vs 2024

Dividends per share, 2025 · 4 payments

Year	Dividends per share	Payments	Change
2026*	$0.48	3	—
2025	$0.64	4	+0.0%
2024	$0.64	4	+0.0%
2023	$0.64	4	+0.0%

Year	Dividends per share	Payments	Change
2026 (partial year)	$0.48	3	—
2025	$0.64	4	+0.0%
2024	$0.64	4	+0.0%
2023	$0.64	4	+0.0%
2022	$0.64	4	+0.0%
2021	$0.64	4	+0.0%
2020	$0.64	4	+0.0%
2019	$0.64	4	+0.0%
2018	$0.64	4	+0.0%
2017	$0.64	4	+300.0%
2016	$0.16	1	—

Most recent payment: $0.16 per share, ex-dividend August 31, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

MLAB Valuation vs Scientific & Technical Instruments Median

Median of 35 stocks

Metric	MLAB	Scientific & Technical Instruments median	vs median
P/E	150.33	39.15	3.8x the median
P/S ratio	2.86	5.24	45% below
Profit margin	1.92%	2.42%	0.5 pts below

Medians across 35 Scientific & Technical Instruments stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Mesa Laboratories, Inc. (MLAB) at $715.04M. It is classified in the Scientific & Technical Instruments industry, within the Technology sector. The company reports 717 employees.

The most recent close on file for MLAB is $127.78, dated September 4, 2026. That is −$0.75 (−0.58%) against the previous close. The 52-week range on file runs from $58.83 to $132.70. The latest close sits 117.2% above that 52-week low.

Financial Health

In fiscal 2025, Mesa Laboratories, Inc. reported revenue of $249.13M. Against the prior fiscal year total of $240.98M, that is a change of +3.38%. The same year closed with net income of $6.71M. The reported profit margin is 1.92%. That is 0.5 percentage points below the Scientific & Technical Instruments median of 2.42%. Trailing earnings per share are 0.85.

Across the 4 fiscal years on file, revenue moves from $219.08M in 2022 to $249.13M in 2025. Of those 4 years, 2 report positive net income.

Valuation Assessment

MLAB trades at a trailing price-to-earnings ratio of 150.33. That is 3.8 times the Scientific & Technical Instruments median of 39.15. The forward P/E on file is 12.44. The price-to-sales ratio is 2.86. On price-to-sales that is 45.4% below the Scientific & Technical Instruments median of 5.24. 35 Scientific & Technical Instruments companies report these metrics, and the medians quoted come from that group.

The reported beta is 0.97. Daily returns over the trailing 10 years annualize to a volatility of 43.78%. The trailing one-year price return is +99.67%. Measured over 10 years, that is +1.73% a year compounded.

Growth & Income

Shareholders receive a dividend, yielding 0.5% on the latest price. At the indicated rate that is $0.64 a share a year. The ex-dividend date on file is August 31, 2026. Dividends are recorded for 11 calendar years; 2026 shows 3 payments totalling $0.48 a share. The year before, 2025, totalled $0.64 a share.

The strongest complete calendar year on file is 2018 at +68.27%; the weakest is 2022 at −49.18%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the price is +63.30% year to date.

Peer Comparison

Mesa Laboratories, Inc. (MLAB) operates in the Scientific & Technical Instruments industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Mesa Laboratories, Inc.	MLAB	$715.04M	150.3
Keysight Technologies, Inc.	KEYS	$55.71B	43.7
Coherent Corp.	COHR	$55.20B	64.1
Garmin Ltd.	GRMN	$53.43B	28.6

The Scientific & Technical Instruments industry average P/E ratio is 39.1x. Mesa Laboratories, Inc. trades at a P/E of 150.3.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Scientific & Technical Instruments Stocks

KEYS

Keysight Technologies, Inc.

$55.71B

COHR

Coherent Corp.

$55.20B

GRMN

Garmin Ltd.

$53.43B

TDY

Teledyne Technologies Incorporated

$28.31B

MKSI

MKS Inc.

$17.60B

FTV

Fortive Corporation

$17.20B

View all Scientific & Technical Instruments stocks →

Popular Technology Stocks

NVDA

NVIDIA Corporation

$5.56T

AAPL

Apple Inc.

$4.67T

MSFT

Microsoft Corporation

$3.71T

TSM

Taiwan Semiconductor Manufacturing Company Limited

$2.22T

AVGO

Broadcom Inc.

$1.70T

View all Technology stocks →

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Visit website →

Mesa Laboratories, Inc. (MLAB) Stock Analysis